Psychotropic medication use in adults with intellectual disability in Queensland, Australia, from 1999 to 2015: a cohort study

被引:11
|
作者
Song, M. [1 ]
Ware, R. [2 ]
Doan, T. N. [3 ]
Harley, D. [1 ]
机构
[1] Mater Res Inst Univ Queensland MRI UQ, Queensland Ctr Intellectual & Dev Disabil QCIDD, Room 233,Aubigny Pl,Raymond Terrace, South Brisbane, Qld 4101, Australia
[2] Griffith Univ, Menzies Hlth Inst Queensland, Nathan, Qld, Australia
[3] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic, Australia
关键词
antipsychotics; challenging behaviour; cohort study; intellectual disability; problem behaviour; psychotropics;
D O I
10.1111/jir.12685
中图分类号
G76 [特殊教育];
学科分类号
040109 ;
摘要
Background Longitudinal data on medication use in adults with intellectual disability (ID) are scarce. We describe the longitudinal use of and factors associated with psychotropic medication prescribing in adults with ID living in the Australian community. Methods Longitudinal data were obtained from adults with ID in the community in Queensland, Australia, between 1999 and 2015. Participant characteristics and medication use information were extracted from baseline questionnaires and health check booklets. Logistic regression was used to investigate the associations between participant characteristics and psychotropic medication use, commencement or cessation. Results Longitudinal data were available for 138 participants on 697 reviews. The proportion of participants prescribed psychotropic medications increased from 43% to 54% between 1999 and 2015. The rates of commencement and cessation of psychotropic medications between consecutive time periods ranged from 9% to 18% and 7% to 15%, respectively. Challenging behaviour was associated with psychotropic medication use (adjusted odds ratio = 4.1; 95% confidence interval: 2.1-7.9). Presence of challenging behaviour, either consistent or newly identified, was positively associated with ongoing use or commencement of psychotropic medications. Conclusions Psychotropic medications are commonly prescribed to adults with ID. Challenging behaviour is positively associated with ongoing use and commencement.
引用
收藏
页码:45 / 56
页数:12
相关论文
共 50 条
  • [1] PSYCHOTROPIC MEDICATION USE IN ADULTS WITH INTELLECTUAL DISABILITY IN QUEENSLAND, AUSTRALIA FROM 1999 TO 2016
    Song, M.
    Harley, D.
    Ware, R.
    Doan, T.
    [J]. JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2019, 63 (07) : 691 - 691
  • [2] Appropriateness of psychotropic medication use in a cohort of adolescents with intellectual disability in Queensland, Australia
    Song, Menghuan
    Ware, Robert S.
    Doan, Tan N.
    McPherson, Lyn
    Trollor, Julian N.
    Harley, David
    [J]. BJPSYCH OPEN, 2020, 6 (06):
  • [3] Prevalence of Psychotropic Medication Use and Psychotropic Polypharmacy in Autistic Adults With or Without Intellectual Disability
    Yoshida, Kazunari
    Lunsky, Yona
    Mueller, Daniel J.
    Desarkar, Pushpal
    [J]. JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2024,
  • [4] QUALITATIVE EXPLORATION OF PSYCHOTROPIC MEDICATION PRESCRIBING FOR ADULTS WITH INTELLECTUAL DISABILITY
    Sheehan, R.
    Strydom, A.
    Hassiotis, A.
    Morant, N.
    [J]. JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2019, 63 (07) : 678 - 678
  • [5] Psychotropic medication use for adults and older adults with intellectual disability; selective review, recommendations and future directions
    Deutsch, Stephen, I
    Burket, Jessica A.
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2021, 104
  • [6] Experiences of psychotropic medication use and decision-making for adults with intellectual disability: a multistakeholder qualitative study in the UK
    Sheehan, Rory
    Hassiotis, Angela
    Strydom, Andre
    Morant, Nicola
    [J]. BMJ OPEN, 2019, 9 (11):
  • [7] Prevalence of psychotropic medication use and association with challenging behaviour in adults with an intellectual disability. A total population study
    Bowring, D. L.
    Totsika, V.
    Hastings, R. P.
    Toogood, S.
    McMahon, M.
    [J]. JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2017, 61 (06) : 604 - 617
  • [8] A structured medication review tool to promote psychotropic medication optimisation for adults with intellectual disability: feasibility study
    Sheehan, Rory
    Strydom, Andre
    Marston, Louise
    Morant, Nicola
    Fiori, Federico
    Santosh, Paramala
    Hassiotis, Angela
    [J]. BMJ OPEN, 2019, 9 (12):
  • [9] Psychotropic medication use in adolescents with intellectual disability living in the community
    Doan, Tan
    Ware, Robert
    McPherson, Lyn
    van Dooren, Kate
    Bain, Christopher
    Carrington, Suzanne
    Einfeld, Stewart
    Tonge, Bruce
    Lennox, Nicholas
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 (01) : 69 - 76
  • [10] Central nervous system medication use in older adults with intellectual disability: Results from the successful ageing in intellectual disability study
    Chitty, Kate M.
    Evans, Elizabeth
    Torr, Jennifer J.
    Iacono, Teresa
    Brodaty, Henry
    Sachdev, Perminder
    Trollor, Julian N.
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2016, 50 (04): : 352 - 362